Washington, D.C., Zürich, Switzerland
The Physicians Committee for Responsible Medicine, a nonprofit that advances human-based science, and InSphero, the global leader in 3D in vitro technology for drug safety and efficacy testing, are pleased to announce the winners of the HUMAIN Award 2023 (Human Advanced In Vitro Model Initiative). The award recognizes researchers working to expand access to and accelerate the uptake of human-specific non-animal approaches.
The five winners of the HUMAIN Award are:
- Dr. Burak Toprakhisar, Postdoctoral Researcher, Vrije Universiteit Brussel, Belgium
Project Title: Revealing the early cellular events in human liver inflammation by using HiPSC
This project aims to explore the initiation and progression of liver disease in a human stem cell-derived liver coculture model by revealing cellular stress activation pathways in real time. - PD Dr. rer. nat. Felicia Gerst, Senior Scientist, University of Tübingen, Germany
Project Title: Impact of pancreatic adipose tissue on islet function
This project aims to better understand how ectopic fat impacts islet function (i.e., the regulation of metabolism and glucose control) and how pancreatic adipose tissues (ectopic fat) contribute to the onset of obesity-related type 2 diabetes. - Prof. Dr. med. Gabriela Kania, Principal Investigator, University Hospital of Zürich, Switzerland
Project Title: Exploring liver effects in a multi-organ-on-a-chip model of cardiac fibrosis across diverse experimental scenarios
This project aims to advance understanding of cardiac fibrosis, a condition that causes scar tissue to build up in the heart, and how the condition plays a role in liver function. The project will use a multi-organ-on-a-chip model of cardiac fibrosis to evaluate the impact on liver tissues under various experimental conditions and treatments. - Dr. Karina Orlowska, Postdoctoral Research Associate, Michigan State University, United States
Project Title: Development of chemical safety screening by high-throughput sequencing
This project will develop a human-relevant scalable workflow for the mechanistic explanation and safety assessment of chemicals and drugs using high-throughput screening. This approach has the potential to provide a comprehensive view of cellular responses within a complex tissue-like context that would accelerate breakthroughs in disease modeling, drug development, and safety assessments. - PD Dr. Ute Wölfle, Principal Investigator & Senior Scientist, University of Freiburg, Germany
Project Title: Influencing the interaction of fatty liver spheroids and psoriasis keratinocytes by liver-protecting herbal remedies
This project aims to investigate whether liver-protecting therapeutics can reduce fatty liver inflammation as well as psoriasis inflammation. This study serves as a starting point to find the most promising herbal liver-protecting compounds that could be used in a later clinical trial to investigate how psoriasis and fatty liver-associated inflammation interact.
The winning laboratories will receive:
- $20,000 toward InSphero technology (Akura™ Spheroid Microplates, 3D InSight™ Microtissues, ARCTis™ Cryo Microtissues) or services (3D InSight™ Services),
- Access to an inaugural one-day training course in the United States or Switzerland, with a $1,000 travel grant per award,
- Two hours of monthly consulting with InSphero experts,
- Up to $2,000 in travel grants to present findings at scientific conferences, and,
- $2,500 towards open-access publication fees.
Next steps for the winners of the HUMAIN Award:
Within the initiative, PCRM and InSphero will support the winners of the HUMAIN Award in their project execution and presentation of scientific findings. The awardees will attend an onsite session at InSphero’s premises in Switzerland, where the 3D cell culture experts will lead a comprehensive hands-on training with the proprietary scalable and reproducible 3D in vitro tools for drug discovery research.
PCRM and InSphero extend their congratulations to the winners of the HUMAIN Award Initiative!
# # # #
About the Physicians Committee for Responsible Medicine
Founded in 1985, the Physicians Committee for Responsible Medicine is a nonprofit organization that promotes preventive medicine, conducts clinical research, and encourages higher standards for ethics and effectiveness in research and training.
About InSphero
InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug discovery in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to inspire the next generation of breakthrough therapies through customer engagement, commitment to innovation, and the model of excellence.
Learn more at insphero.com and follow the company on LinkedIn.
Media Contacts
PCRM
Reina Pohl
202-527-7326
rpohl@pcrm.org
InSphero
Rositsa Hadzhipetrova
rositsa.hadzhipetrova@insphero.com
